Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis
Antimicrobial Agents and Chemotherapy, 06/29/09
Spellberg B et al. - Deferasirox was administered for an average of 14 days at 5 to 20 mg/kg of body weight/day. Deferasirox treatment was not associated with changes in renal or liver function, complete blood count, or transplant immunosuppressive levels. Thus, deferasirox appears safe as an adjunctive therapy for mucormycosis.
Related Articles
A Successful Combined Endovascular and Surgical Treatment of A Cranial Base Mucormycosis With An Associated Internal Carotid Artery Pseudoaneurysm
Neurosurgery, 10/07/09
Relevance Score: 88%
Rhino-Orbital-Cerebral Mucormycosis: A Lethal Complication of Body Dysmorphic Disorder
Ophthalmic Plastic and Reconstructive Surgery, 10/06/09
Relevance Score: 83%
Ulcerative leg nodules in a transplant recipient
Cleveland Clinic Journal of Medicine, 10/16/09
Relevance Score: 82%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-Term Complete Regression of Nodal Marginal Zone Lymphoma Transformed Into Diffuse Large B-Cell Lymphoma With Highly Active Antiretroviral Therapy Alone in Human Immunodeficiency Virus Infection
The American Journal of the Medical Sciences, 12/18/09
Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria
Therapeutics and Clinical Risk Management, 12/18/09
Temporal Reduction of HIV Type 1 Viral Load in Breast Milk by Single-Dose Nevirapine during Prevention of MTCT
AIDS Research and Human Retroviruses, 12/18/09
Today in Fungal Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Activation of platelets by Aspergillus fumigatus Potential role in the immunopathogenesis of aspergillosis
Infection and Immunity, 12/18/09
TLR4 signaling leads to a more severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells
Infection and Immunity, 12/18/09
Computed tomographic scan evaluation of pulmonary blastomycosis
Canadian Journal of Infectious Diseases, 12/17/09
Article Search
Sponsor


See Latest Articles


